Indian Pharmaceutical Market
India Pharmaceutical Industry Research 2024: $105+ Billion Market Trends, Regional Insights, Competition, Forecasts and Opportunities, 2020-2030
September 11, 2024 11:50 ET | Research and Markets
Dublin, Sept. 11, 2024 (GLOBE NEWSWIRE) -- The "India Pharmaceutical Market, By Region, Competition, Forecast and Opportunities, 2020-2030F" report has been added to ResearchAndMarkets.com's...
Regeneron Logo.jpg
Dupixent® (dupilumab) Phase 3 Trial Confirms Significant Improvements in Itch and Hives for Patients with Chronic Spontaneous Urticaria (CSU)
September 11, 2024 01:04 ET | Regeneron Pharmaceuticals, Inc.
Confirming the results of Study A, this second pivotal trial in biologic-naïve patients met primary and key secondary endpoints, showing treatment with Dupixent resulted in a nearly 50% reduction in...
Regeneron Logo.jpg
Dupixent® (dupilumab) Is the First and Only Biologic to Achieve Significant Improvements in Disease Remission and Symptoms in Bullous Pemphigoid (BP) Positive Pivotal Trial
September 11, 2024 00:59 ET | Regeneron Pharmaceuticals, Inc.
Trial met the primary and all key secondary endpoints in adults with moderate-to-severe disease; five times more patients achieved sustained disease remission with Dupixent than placebo Dupixent is...
logo.jpg.jpg
ViaDerma Completes First Shipment of 500,000 Units to Nigeria
September 10, 2024 08:00 ET | ViaDerma, Inc.
LOS ANGELES, Sept. 10, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC: VDRM), a specialty pharmaceutical company known for developing innovative transdermal drug delivery systems, is pleased to...
Aclaris_Logo_CLR®.jpg
Aclaris Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference
September 10, 2024 07:00 ET | Aclaris Therapeutics, Inc.
Aclaris Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference
BioNTX StandardMed_Res.jpg
BioNTX Unveils 2024 Rising Stars at the iC³® Life Science & Healthcare Innovation Summit
September 05, 2024 11:06 ET | BioNTX
IRVING, Texas, Sept. 05, 2024 (GLOBE NEWSWIRE) -- As Texas continues to grow as a biotech and healthcare innovative hub, BioNTX is honored to announce the 2024 Rising Stars, a select group of...
lumos.png
Lumos Pharma Announces Abstract Accepted for Presentation at September Medical Meeting, SLEP 2024
September 05, 2024 09:00 ET | Lumos Pharma, Inc.
AUSTIN, Texas, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that an...
YSEOP_LOGO_FINAL-PURPLE-_-YELLOW (1).png
Yseop Joins Veeva’s AI Partner Program to Accelerate Regulatory Document Writing and AI-Driven Content Automation
September 05, 2024 09:00 ET | Yseop
NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Yseop, a leader in artificial intelligence (AI) enterprise software, is excited to announce it has joined the Veeva AI Partner Program. As a Veeva AI...
DMR Logo.png
Next Generation Sequencing Market is Anticipated to Attain USD 92.2 Billion in Revenue by 2033 , at a CAGR 23.8%: Insights by Dimension Market Research
September 04, 2024 11:36 ET | Dimension Market Research
New York, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Overview The Global Next Generation Sequencing Market size is expected to reach USD 13.5 billion by 2024 and it is further anticipated to reach a...
plus_logo.png
Plus Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
September 04, 2024 07:30 ET | Plus Therapeutics Inc.
Plus Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference